96 related articles for article (PubMed ID: 18674901)
1. Synthesis and biological evaluation of N-mercaptoacylproline and N-mercaptoacylthiazolidine-4-carboxylic acid derivatives as leukotriene A4 hydrolase inhibitors.
Enomoto H; Morikawa Y; Miyake Y; Tsuji F; Mizuchi M; Suhara H; Fujimura K; Horiuchi M; Ban M
Bioorg Med Chem Lett; 2008 Aug; 18(16):4529-32. PubMed ID: 18674901
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of N-mercaptoacylcysteine derivatives as leukotriene A4 hydrolase inhibitors.
Enomoto H; Morikawa Y; Miyake Y; Tsuji F; Mizuchi M; Suhara H; Fujimura K; Horiuchi M; Ban M
Bioorg Med Chem Lett; 2009 Jan; 19(2):442-6. PubMed ID: 19042128
[TBL] [Abstract][Full Text] [Related]
3. Discovery of novel and potent aryl diamines as leukotriene A4 hydrolase inhibitors.
Khim SK; Bauman J; Evans J; Freeman B; King B; Kirkland T; Kochanny M; Lentz D; Liang A; Mendoza L; Phillips G; Tseng JL; Wei RG; Ye H; Yu L; Parkinson J; Guilford WJ
Bioorg Med Chem Lett; 2008 Jul; 18(14):3895-8. PubMed ID: 18590959
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of N-alkyl glycine amides as potent inhibitors of leukotriene A4 hydrolase.
Ye B; Bauman J; Chen M; Davey D; Khim SK; King B; Kirkland T; Kochanny M; Liang A; Lentz D; May K; Mendoza L; Phillips G; Selchau V; Schlyer S; Tseng JL; Wei RG; Ye H; Parkinson J; Guilford WJ
Bioorg Med Chem Lett; 2008 Jul; 18(14):3891-4. PubMed ID: 18586492
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of leukotriene A4 hydrolase/aminopeptidase by captopril.
Orning L; Krivi G; Bild G; Gierse J; Aykent S; Fitzpatrick FA
J Biol Chem; 1991 Sep; 266(25):16507-11. PubMed ID: 1885582
[TBL] [Abstract][Full Text] [Related]
6. Feasibility and physiological relevance of designing highly potent aminopeptidase-sparing leukotriene A4 hydrolase inhibitors.
Numao S; Hasler F; Laguerre C; Srinivas H; Wack N; Jäger P; Schmid A; Osmont A; Röthlisberger P; Houguenade J; Bergsdorf C; Dawson J; Carte N; Hofmann A; Markert C; Hardaker L; Billich A; Wolf RM; Penno CA; Bollbuck B; Miltz W; Röhn TA
Sci Rep; 2017 Oct; 7(1):13591. PubMed ID: 29051536
[TBL] [Abstract][Full Text] [Related]
7. Activation and inhibition of leukotriene A4 hydrolase aminopeptidase activity by diphenyl ether and derivatives.
Jiang X; Zhou L; Wei D; Meng H; Liu Y; Lai L
Bioorg Med Chem Lett; 2008 Dec; 18(24):6549-52. PubMed ID: 18952425
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of glutamic acid analogs as potent inhibitors of leukotriene A4 hydrolase.
Kirkland TA; Adler M; Bauman JG; Chen M; Haeggström JZ; King B; Kochanny MJ; Liang AM; Mendoza L; Phillips GB; Thunnissen M; Trinh L; Whitlow M; Ye B; Ye H; Parkinson J; Guilford WJ
Bioorg Med Chem; 2008 May; 16(9):4963-83. PubMed ID: 18394906
[TBL] [Abstract][Full Text] [Related]
9. Thermodynamic properties of leukotriene A
Wittmann SK; Kalinowsky L; Kramer JS; Bloecher R; Knapp S; Steinhilber D; Pogoryelov D; Proschak E; Heering J
Bioorg Med Chem; 2016 Nov; 24(21):5243-5248. PubMed ID: 27651294
[TBL] [Abstract][Full Text] [Related]
10. Discovery of novel leukotriene A4 hydrolase inhibitors based on piperidine and piperazine scaffolds.
Sandanayaka V; Mamat B; Bhagat N; Bedell L; Halldorsdottir G; Sigthorsdottir H; Andrésson T; Kiselyov A; Gurney M; Singh J
Bioorg Med Chem Lett; 2010 May; 20(9):2851-4. PubMed ID: 20371179
[TBL] [Abstract][Full Text] [Related]
11. Optimization of 5-hydroxytryptamines as dual function inhibitors targeting phospholipase A2 and leukotriene A4 hydrolase.
Meng H; Liu Y; Zhai Y; Lai L
Eur J Med Chem; 2013 Jan; 59():160-7. PubMed ID: 23220644
[TBL] [Abstract][Full Text] [Related]
12. Potent and selective inhibitors of leukotriene A4 hydrolase: effects on purified enzyme and human polymorphonuclear leukocytes.
Wetterholm A; Haeggström JZ; Samuelsson B; Yuan W; Munoz B; Wong CH
J Pharmacol Exp Ther; 1995 Oct; 275(1):31-7. PubMed ID: 7562564
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and biological evaluation of the N-diarylalkenyl-piperidinecarboxylic acid derivatives as GABA uptake inhibitors (I).
Zheng J; Wen R; Luo X; Lin G; Zhang J; Xu L; Guo L; Jiang H
Bioorg Med Chem Lett; 2006 Jan; 16(1):225-7. PubMed ID: 16246548
[TBL] [Abstract][Full Text] [Related]
14. Discovery, SAR and X-ray structure of 1H-benzimidazole-5-carboxylic acid cyclohexyl-methyl-amides as inhibitors of inducible T-cell kinase (Itk).
Moriarty KJ; Takahashi H; Pullen SS; Khine HH; Sallati RH; Raymond EL; Woska JR; Jeanfavre DD; Roth GP; Winters MP; Qiao L; Ryan D; DesJarlais R; Robinson D; Wilson M; Bobko M; Cook BN; Lo HY; Nemoto PA; Kashem MA; Wolak JP; White A; Magolda RL; Tomczuk B
Bioorg Med Chem Lett; 2008 Oct; 18(20):5545-9. PubMed ID: 18819799
[TBL] [Abstract][Full Text] [Related]
15. Effect of alpha lipoic acid on leukotriene A
Torres MJ; Fierro A; Pessoa-Mahana CD; Romero-Parra J; Cabrera G; Faúndez M
Eur J Pharmacol; 2017 Mar; 799():41-47. PubMed ID: 28132911
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological characterization of SC-57461A (3-[methyl[3-[4-(phenylmethyl)phenoxy]propyl]amino]propanoic acid HCl), a potent and selective inhibitor of leukotriene A(4) hydrolase I: in vitro studies.
Askonas LJ; Kachur JF; Villani-Price D; Liang CD; Russell MA; Smith WG
J Pharmacol Exp Ther; 2002 Feb; 300(2):577-82. PubMed ID: 11805219
[TBL] [Abstract][Full Text] [Related]
17. Fused bicyclic heteroarylpiperazine-substituted L-prolylthiazolidines as highly potent DPP-4 inhibitors lacking the electrophilic nitrile group.
Yoshida T; Akahoshi F; Sakashita H; Sonda S; Takeuchi M; Tanaka Y; Nabeno M; Kishida H; Miyaguchi I; Hayashi Y
Bioorg Med Chem; 2012 Aug; 20(16):5033-41. PubMed ID: 22824762
[TBL] [Abstract][Full Text] [Related]
18. Discovery of 4-[(2S)-2-{[4-(4-chlorophenoxy)phenoxy]methyl}-1-pyrrolidinyl]butanoic acid (DG-051) as a novel leukotriene A4 hydrolase inhibitor of leukotriene B4 biosynthesis.
Sandanayaka V; Mamat B; Mishra RK; Winger J; Krohn M; Zhou LM; Keyvan M; Enache L; Sullins D; Onua E; Zhang J; Halldorsdottir G; Sigthorsdottir H; Thorlaksdottir A; Sigthorsson G; Thorsteinnsdottir M; Davies DR; Stewart LJ; Zembower DE; Andresson T; Kiselyov AS; Singh J; Gurney ME
J Med Chem; 2010 Jan; 53(2):573-85. PubMed ID: 19950900
[TBL] [Abstract][Full Text] [Related]
19. Discovery of dual target inhibitors against cyclooxygenases and leukotriene A4 hydrolyase.
Chen Z; Wu Y; Liu Y; Yang S; Chen Y; Lai L
J Med Chem; 2011 May; 54(10):3650-60. PubMed ID: 21542630
[TBL] [Abstract][Full Text] [Related]
20. N-Benzyl-indolo carboxylic acids: Design and synthesis of potent and selective adipocyte fatty-acid binding protein (A-FABP) inhibitors.
Barf T; Lehmann F; Hammer K; Haile S; Axen E; Medina C; Uppenberg J; Svensson S; Rondahl L; Lundbäck T
Bioorg Med Chem Lett; 2009 Mar; 19(6):1745-8. PubMed ID: 19217286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
